PolyNovo Limited (ASX:PNV)
Australia · Delayed Price · Currency is AUD 0.8700
+0.0250 (2.96%)
Oct 27, 2026, 4:10 PM AEDT
PolyNovo Market Cap
PolyNovo has a market cap or net worth of 601.03 million as of October 27, 2026. It is the 15,829th most valuable company in the world and the 301st biggest in Australia. Its market cap has decreased by 32.82% in one year.
Market Cap
601.03M
Enterprise Value
583.17M
Revenue
149.85M
Global Rank
Country Rank
#301 Australia
PE Ratio
82.86
ChartMarket Cap Chart
Since August 23, 1999, PolyNovo's market cap has increased from 33.09M to 601.03M, an increase of 1,716.52%. That is a compound annual growth rate of 11.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2026 | 601.03M | -29.27% |
| Dec 31, 2025 | 849.74M | -39.71% |
| Dec 31, 2024 | 1.41B | 23.37% |
| Dec 29, 2023 | 1.14B | -17.80% |
| Dec 30, 2022 | 1.39B | 37.79% |
| Dec 31, 2021 | 1.01B | -60.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| 4DMedical | 2.20B |
| Imricor Medical Systems | 469.83M |
| Aroa Biosurgery | 183.33M |
| EMVision Medical Devices | 143.62M |
| EBR Systems | 105.68M |
| SomnoMed | 65.93M |
| Lumos Diagnostics Holdings | 65.10M |
| Saluda Medical | 63.01M |